{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:22:40Z","timestamp":1786371760634,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T00:00:00Z","timestamp":1602892800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Successful canine sarcoptic mange treatment requires immediate efficacy to eliminate active mites, and sustained activity to prevent re-infestation from in-contact animals and fomites. With extended acaricidal activity, fluralaner has been shown to be effective for treating this disease. To confirm this potential under field conditions, two fluralaner formulations were administered to mite-infested, client-owned dogs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Households qualified for inclusion if they had at least one dog positive for\n                      <jats:italic>Sarcoptes scabiei<\/jats:italic>\n                      mites, confirmed by skin scraping, and at least one dog with clinical signs evocative of sarcoptic mange. Households were allocated to groups of dogs to receive a single treatment with either oral (Bravecto\n                      <jats:sup>\u00ae<\/jats:sup>\n                      chewable tablets, MSD Animal Health) or topical (Bravecto\n                      <jats:sup>\u00ae<\/jats:sup>\n                      Spot-on, MSD Animal Health), fluralaner at a dose of \u2265 25 mg\/kg (range 25\u201356 mg\/kg) on Day 0, or two treatments with oral sarolaner (Simparica\n                      <jats:sup>\u00ae<\/jats:sup>\n                      tablets, Zoetis) (Days 0 and 28) at \u2265 2 mg\/kg (2\u20134 mg\/kg). All dogs in each household were treated with the same product. On the enrolment day and subsequently on Days 28, 56 and 84, deep skin scrapings were taken from at least five different body areas judged to be most likely to have active mite infestation. At each visit, the dog\u2019s mange-associated skin lesions were recorded, and pruritus level was assessed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 98 participating households and 135 dogs enrolled across Albania, France, Italy and Portugal. On Day 28, more than 90% of dogs in each group were negative for mites. On Days 56 and 84, all study dogs were free of mites and most dermatological signs of sarcoptic mange had resolved. There were no treatment-related adverse events in any group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      A single treatment of client-owned, sarcoptic mange-affected dogs with either fluralaner chewable tablets or fluralaner spot-on formulation proved a safe and effective treatment of infestations with\n                      <jats:italic>S. scabiei<\/jats:italic>\n                      var.\n                      <jats:italic>canis<\/jats:italic>\n                      , maintained through 84 days (12 weeks) after treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-020-04395-6","type":"journal-article","created":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T02:02:39Z","timestamp":1602900159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy of orally and topically administered fluralaner (Bravecto\u00ae) for treatment of client-owned dogs with sarcoptic mange under field conditions"],"prefix":"10.1186","volume":"13","author":[{"given":"Rafael","family":"Chiummo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivo","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Plehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zschiesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Roepke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,17]]},"reference":[{"key":"4395_CR1","unstructured":"Miller WH, Griffin CE, Campbell KL. Parasitic skin disease. In: Muller and Kirk\u2019s Small Animal Dermatology. 7th ed. Elsevier Mosby: St Louis, Missouri. 2013. p. 284\u2013342."},{"key":"4395_CR2","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1001\/archderm.1974.01630100032008","volume":"110","author":"N Ernest","year":"1974","unstructured":"Ernest N, Charlesworth MC, Jeffrey L, Johnson VC. An epidemic of canine scabies in man. Arch Dermatol. 1974;110:572\u20134.","journal-title":"Arch Dermatol."},{"key":"4395_CR3","doi-asserted-by":"publisher","DOI":"10.1079\/9781780640372.0000","volume-title":"The Encyclopedia of Medical & Veterinary Entomology","author":"RC Russell","year":"2013","unstructured":"Russell RC, Otranto D, Wall RL. The Encyclopedia of Medical & Veterinary Entomology. Wallingford: CABI; 2013."},{"key":"4395_CR4","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/s13071-017-2234-1","volume":"10","author":"LG Arlian","year":"2017","unstructured":"Arlian LG, Morgan MS. A review of Sarcoptes scabiei: past present and future. Parasit Vectors. 2017;10:297.","journal-title":"Parasit Vectors."},{"key":"4395_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jaad.2019.05.109","volume":"82","author":"C Thomas","year":"2020","unstructured":"Thomas C, Coates SJ, Engelman D, Chosidow O, Chang AY. Ectoparasites: Scabies. J Am Acad Dermatol. 2020;82:533\u201348.","journal-title":"J Am Acad Dermatol."},{"key":"4395_CR6","unstructured":"WHO. Neglected tropical diseases. Scabies and other ectoparasites. Geneva: World Health Organization; 2017. https:\/\/www.who.int\/neglected_diseases\/diseases\/scabies-and-other-ectoparasites\/en\/. Accessed 21 Jul 2020."},{"key":"4395_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13071-016-1367-y","volume":"9","author":"J Taenzler","year":"2016","unstructured":"Taenzler J, Gale B, Zschiesche E, Roepke RK, Heckeroth AR. The effect of water and shampooing on the efficacy of fluralaner spot-on solution against Ixodes ricinus and Ctenocephalides felis infestations in dogs. Parasit Vectors. 2016;9:233.","journal-title":"Parasit Vectors."},{"key":"4395_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s13071-016-1719-7","volume":"9","author":"K Pfister","year":"2016","unstructured":"Pfister K, Armstrong R. Systemically and cutaneously distributed ectoparasiticides: a review of the efficacy against ticks and fleas on dogs. Parasit Vectors. 2016;9:436.","journal-title":"Parasit Vectors."},{"key":"4395_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s13071-017-2389-9","volume":"10","author":"H Dongus","year":"2017","unstructured":"Dongus H, Meyer L, Armstrong R. Water immersion of dogs close to the time of topical fluralaner treatment does not reduce efficacy against a subsequent experimental challenge with Rhipicephalus sanguineus (sensu lato). Parasit Vectors. 2017;10:441.","journal-title":"Parasit Vectors."},{"key":"4395_CR10","doi-asserted-by":"crossref","unstructured":"Petersen I, Chiummo R, Zschiesche E, Karas\u2011Tecza J, Rapti D, Roepke R, Thomas E. A European field assessment of the efficacy of fluralaner (Bravecto\u00ae) chewable and spot-on formulations for treatment of dogs with generalized demodicosis Parasit Vectors. 2020;13:304","DOI":"10.1186\/s13071-020-04159-2"},{"key":"4395_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1756-3305-7-85","volume":"7","author":"S Kilp","year":"2014","unstructured":"Kilp S, Ramirez D, Allan MJ, Roepke RK, Nuernberger MC. Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration. Parasit Vectors. 2014;7:85.","journal-title":"Parasit Vectors."},{"key":"4395_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13071-016-1564-8","volume":"9","author":"S Kilp","year":"2016","unstructured":"Kilp S, Ramirez D, Allan MJ, Roepke RK. Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration. Parasit Vectors. 2016;9:296.","journal-title":"Parasit Vectors."},{"key":"4395_CR13","doi-asserted-by":"crossref","unstructured":"Taenzler J, Liebenberg J, Roepke RK, Fr\u00e9nais R, Heckeroth AR. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs. Parasit Vectors. 2016;9:392.","DOI":"10.1186\/s13071-016-1670-7"},{"key":"4395_CR14","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/vde.12363","volume":"27","author":"C Romero","year":"2016","unstructured":"Romero C, Heredia R, Pineda J, Serrano JA, Mendoza GD, Tr\u00e1pala P, et al. Efficacy of fluralaner in 17 dogs with sarcoptic mange. Vet Dermatol. 2016;27:353\u201388.","journal-title":"Vet Dermatol."},{"key":"4395_CR15","unstructured":"EMEA. VICH Topic GL9 (GCP). Guideline on Good Clinical Practices. The European Agency for the Evaluation of Medicinal Products (EMWA\/CVMP\/VICH\/595\/98-Final). 2000. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/10\/WC500004343.pdf. Accessed 10 Aug 2019."},{"key":"4395_CR16","unstructured":"European Medicines Agency. Guideline on statistical principles for veterinary clinical trials (EMA\/CVMP\/EWP\/81976\/2010). 2010. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/draft-guideline-statistical-principles-veterinary-clinical-trials_en.pdf. Accessed 10 Aug 2019."},{"key":"4395_CR17","unstructured":"European Medicines Agency. Demonstration of efficacy of ectoparasiticides (7AE17a). 1994. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/demonstration-efficacy-ectoparasiticides_en.pdf. Accessed 10 Aug 2019."},{"key":"4395_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1051\/parasite\/2016026","volume":"23","author":"F Beugnet","year":"2016","unstructured":"Beugnet F, de Vos C, Liebenberg J, Halos L, Larsen D, Fourie J. Efficacy of afoxolaner in clinical field study in dogs naturally infested with Sarcoptes scabiei. Parasite. 2016;23:26.","journal-title":"Parasite."},{"key":"4395_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1051\/parasite\/2018064","volume":"25","author":"V Hampel","year":"2018","unstructured":"Hampel V, Knaus M, Sch\u00e4fer J, Beugnet F, Rehbein S. Treatment of canine sarcoptic mange with afoxolaner (NexGard\u00ae) and afoxolaner plus milbemycin oxime (NexGard Spectra\u00ae) chewable tablets: efficacy under field conditions in Portugal and Germany. Parasite. 2018;25:63.","journal-title":"Parasite."},{"key":"4395_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.vetpar.2016.02.017","volume":"222","author":"C Becskei","year":"2016","unstructured":"Becskei C, De Bock F, Illambas J, Cherni JA, Fourie JJ, Lane M, et al. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica\u2122), for the treatment of sarcoptic mange in dogs. Vet Parasitol. 2016;222:56\u201361.","journal-title":"Vet Parasitol."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04395-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-020-04395-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-020-04395-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T19:42:05Z","timestamp":1634413325000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-020-04395-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,17]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4395"],"URL":"https:\/\/doi.org\/10.1186\/s13071-020-04395-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738860285.793582904","asserted-by":"object"}]},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,17]]},"assertion":[{"value":"4 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was in alignment with national and global guidelines, and owners of all dogs were fully advised of all study procedures prior to signing informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"RC, IP, CP, EZ, RR and ET are employees of MSD Animal Health.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"524"}}